Serum amyloid A levels in acute graft-versus-host disease in bone marrow transplant recipients

APMIS. 1991 Jul;99(7):674-6. doi: 10.1111/j.1699-0463.1991.tb01245.x.

Abstract

We studied serum amyloid A levels of 31 bone marrow transplant recipients with and without acute graft-versus-host disease. Before transplantation the mean SAA concentration was 5.1 +/- 0.8 mg/l (mean +/- SEM). It remained low in patients with no signs of aGVHD but increased significantly during aGVHD to 54.0 +/- 8.2 mg/l (p less than 0.001 compared to pre-BMT value). Severe infections also induced high SAA levels.

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Bone Marrow Transplantation / immunology*
  • Graft vs Host Disease / blood*
  • Graft vs Host Disease / drug therapy
  • Humans
  • Serum Amyloid A Protein / analysis*

Substances

  • Adrenal Cortex Hormones
  • Serum Amyloid A Protein